Matthew Vincent Dolan, EVP Strategy and Corporate: Dexcom DXCM Sell · Filed 24/03/14

Trade details

Type: Insider sale
Amount: $901,891.1
Shares · price: 6,710 sh · $134.41 a share
Held after: 48,570 sh
Stock: Dexcom DXCM
Person: Matthew Vincent DolanEVP Strategy and Corporate
Trade date: 24/03/12
Filed: 24/03/14
Days to filing: 2 days

Sold 12.1% of holdings

Share of holding sold: 12.1%

Dexcom trades, last 26 weeks

What else happened in Dexcom around then

Filed or reported within 30 days of the trade day · 24/02/11~24/04/11

Matthew Vincent Dolan's recent trades

Matthew Vincent DolanEVP, Strategy & Corporate Dev
SellDexcom
Sell
Dexcom
DXCM
$102.8K
1,183 sh
$102.8K
Filed 25/01/30
Traded 25/01/29
Matthew Vincent DolanEVP Strategy and Corporate Dev
Sell10b5-1 planDexcom
Sell10b5-1 plan
Dexcom
DXCM
$306.7K
2,423 sh
$306.7K
Filed 24/05/16
Traded 24/05/15
Matthew Vincent DolanEVP Strategy and Corporate Dev
Sell10b5-1 planDexcom
Sell10b5-1 plan
Dexcom
DXCM
$274.2K
1,990 sh
$274.2K
Filed 24/04/16
Traded 24/04/15
Matthew Vincent DolanEVP Strategy & Corp Dev
Sell10b5-1 planDexcom
Sell10b5-1 plan
Dexcom
DXCM
$243.6K
1,886 sh
$243.6K
Filed 24/03/19
Traded 24/03/15
Matthew Vincent DolanEVP Strategy & Corp Dev
Sell10b5-1 planDexcom
Sell10b5-1 plan
Dexcom
DXCM
$171.8K
1,314 sh
$171.8K
Filed 24/03/19
Traded 24/03/15